Anti-recurrence Treatment of Postresection on HCC Patients With MVI Presence and Over-expression of ASPH
Launched by EASTERN HEPATOBILIARY SURGERY HOSPITAL · Oct 26, 2015
Trial Information
Current as of May 19, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Via clinical diagnosis and confirm it is primary liver cancer
- • 2. Pathological evidence of HCC
- • 3. Confirm presence of MVI and over-expression of ASPH after opreation
- • 4. Within Milan criteria
- • 5. Estimate tumor can gain treatment of curing operation
- • 6. No evidence for extrahepatic metestasis
- • 7. liver function ：Child-Pugh A/B
- Exclusion Criteria:
- • 1. Reject to attend
- • 2. Impossible to come to our hospital for physical examination regularly
- • 3. Patients with apparent cardiac, pulmonary, cerebral and renal dysfunction
- • 4. Female with pregnancy or during the lactation period
About Eastern Hepatobiliary Surgery Hospital
Eastern Hepatobiliary Surgery Hospital is a premier medical institution specializing in hepatobiliary and pancreatic surgeries, renowned for its cutting-edge research and clinical excellence. With a commitment to advancing patient care through innovative surgical techniques and comprehensive research initiatives, the hospital plays a pivotal role in the development and execution of clinical trials aimed at improving outcomes for patients with liver, gallbladder, and pancreatic conditions. Its multidisciplinary team of experts collaborates to ensure rigorous adherence to ethical standards and protocols, fostering a research environment that prioritizes patient safety and scientific integrity.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, Shanghai, China
Patients applied
Trial Officials
Shen Feng, MD
Principal Investigator
Eastern Hepatobiliary Surgery Hospital, Second Military Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials